Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trialSusan L. Samson, Mandeep Bajaj|Diabetologia|2011Cited by 107
Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signallingRichard Holmes, Mandeep Bajaj|Diabetologia|2011Cited by 36